Mineralys Therapeutics Stock (NASDAQ: MLYS) stock price, news, charts, stock research, profile.
You can purchase shares of Mineralys Therapeutics (NASDAQ:MLYS) through any online brokerage.
Other companies in Mineralys Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT) and Pharming (NASDAQ:PHAR).
Mineralys Therapeutics has a consensus price target of $34.29.
The stock price for Mineralys Therapeutics (NASDAQ: MLYS) is $12.39 last updated November 14, 2024 at 2:35 PM EST.
There are no upcoming dividends for Mineralys Therapeutics.
Mineralys Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Mineralys Therapeutics.
Mineralys Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.